Explore more Johnson & Johnson sites:
Share
Back to top
Janssen
-
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
-
We spoke to a scientist behind a treatment for the disease that was recently FDA-approved for adolescents ages 12 to 18 to learn how it could give them new hope.
-
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
-
More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.
-
Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
-
From cultural stigma to language barriers, getting necessary treatment can be challenging for these groups. For Hispanic Heritage Month, learn more about what the company is doing to help people surmount unique obstacles to get the resources they need.
-
Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.
-
A life-threatening condition that afflicts young cancer patients. A rare and painful form of pediatric arthritis. Learn about how Johnson & Johnson is innovating to use existing medications to help kids with these illnesses—and meet two women on the forefront of this game-changing work.
-
Johnson & Johnson's Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That's where he met Tiko Kerr, who became one of the first patients to take the company's HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.
-
Two new Johnson & Johnson initiatives aim to remove the obstacles people of color and the LGBTQIA+ community have historically faced in getting help with mental illness. The head of Janssen Neuroscience, Courtney Billington, explains why breaking these barriers is a priority—and a personal mission.
-
Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
-
As global temperatures continue to rise, so too does the incidence of this mosquito-borne virus. For World NTD Day, learn the latest about this growing health threat and how Johnson & Johnson is working to combat it.
-
Championing global health equity, advancing environmental health and empowering its employees to be their best are just some of the ways Johnson & Johnson is working to help improve the well-being of people around the world. The company's 2021 Health for Humanity Report reveals just how far it's come toward these ambitious goals.
-
Injections that allow people with schizophrenia to go longer between treatments. Digital tools that may lead to the creation of more effective medications. Programs that ensure mental illness is properly diagnosed. These are just a few of the ways Johnson & Johnson is addressing the largest unmet need in healthcare.
-
Over the past few decades, advances in the study and treatment of this inflammatory bowel disease have rapidly accelerated. We spoke to the experts to learn the latest about managing Crohn's disease—and what other potential breakthroughs are on the horizon.
